Paper778262
Humoral immunity in experimental syphilis. II. The relationship of neutralizing factors in immune serum to acquired resistance.
Bishop NH and 1 other. J Immunol, 1976. Cited by 101 papers, by iCite.
Cite this record
ConductScience Library. Humoral immunity in experimental syphilis. II. The relationship of neutralizing factors in immune serum to acquired resistance. Papers, record 778262. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/778262
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Humoral immunity in experimental syphilis. II. The relationship of neutralizing factors in immune serum to acquired resistance.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immune Sera | Major topic |
| Immunity | Major topic |
| Syphilis | Major topic |
| Animals | |
| Antibodies, Bacterial | |
| Flocculation Tests | |
| Hot Temperature | |
| Male | |
| Muramidase | |
| Neutralization Tests | |
| Rabbits | |
| Time Factors | |
| Treponema Immobilization Test | |
| Treponema pallidum |
Source PubMed
Cited by62
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 101 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42628507 | Looking Down the Road: Development of a Future Syphilis Vaccine. | Sex Transm Dis | 2026 | https://conductscience.org/library/papers/42628507 | PubMed |
| 42383911 | Advancements in Syphilis Vaccine Development. | Sex Transm Dis | 2026 | https://conductscience.org/library/papers/42383911 | PubMed |
| 42324733 | An mRNA-LNP vaccine expressing TP0435 provides protective immunity in rabbits against Treponema pallidum challenge. | Emerg Microbes Infect | 2026 | https://conductscience.org/library/papers/42324733 | PubMed |
| 42262076 | High-throughput profiling of the IgG and IgA response to the Treponema pallidum subsp. pallidum proteome in syphilis patients. | mBio | 2026 | https://conductscience.org/library/papers/42262076 | PubMed |
| 41550954 | Antibodies directed against extracellular loops of FadL orthologs disrupt outer membrane integrity and neutralize infectivity of Treponema pallidum, the syphilis spirochete. | Front Immunol | 2025 | https://conductscience.org/library/papers/41550954 | PubMed |
| 39262771 | A novel pan-proteome array for high-throughput profiling of the humoral response to Treponema pallidum. | iScience | 2024 | https://conductscience.org/library/papers/39262771 | PubMed |
| 37090699 | Syphilis vaccine: challenges, controversies and opportunities. | Front Immunol | 2023 | https://conductscience.org/library/papers/37090699 | PubMed |
| 29022569 | Syphilis. | Nat Rev Dis Primers | 2017 | https://conductscience.org/library/papers/29022569 | PubMed |
| 22133883 | Syphilis: using modern approaches to understand an old disease. | J Clin Invest | 2011 | https://conductscience.org/library/papers/22133883 | PubMed |
| 17403876 | CD4+ lymphocytes and gamma interferon predominate in local immune responses in early experimental syphilis. | Infect Immun | 2007 | https://conductscience.org/library/papers/17403876 | PubMed |
| 16418521 | Biological basis for syphilis. | Clin Microbiol Rev | 2006 | https://conductscience.org/library/papers/16418521 | PubMed |
| 15845516 | A monoclonal antibody that conveys in vitro killing and partial protection in experimental syphilis binds a phosphorylcholine surface epitope of Treponema pallidum. | Infect Immun | 2005 | https://conductscience.org/library/papers/15845516 | PubMed |
| 14500529 | Antibody responses elicited against the Treponema pallidum repeat proteins differ during infection with different isolates of Treponema pallidum subsp. pallidum. | Infect Immun | 2003 | https://conductscience.org/library/papers/14500529 | PubMed |
| 10377149 | Correlation of immunity in experimental syphilis with serum-mediated aggregation of Treponema pallidum rare outer membrane proteins. | Infect Immun | 1999 | https://conductscience.org/library/papers/10377149 | PubMed |
| 9989979 | Treponema pallidum major sheath protein homologue Tpr K is a target of opsonic antibody and the protective immune response. | J Exp Med | 1999 | https://conductscience.org/library/papers/9989979 | PubMed |
| 9126440 | Surface antigens of the syphilis spirochete and their potential as virulence determinants. | Emerg Infect Dis | 1997 | https://conductscience.org/library/papers/9126440 | PubMed |
| 9119485 | Conservation of the 15-kilodalton lipoprotein among Treponema pallidum subspecies and strains and other pathogenic treponemes: genetic and antigenic analyses. | Infect Immun | 1997 | https://conductscience.org/library/papers/9119485 | PubMed |
| 9023206 | Sequence analysis and recombinant expression of a 28-kilodalton Treponema pallidum subsp. pallidum rare outer membrane protein (Tromp2). | J Bacteriol | 1997 | https://conductscience.org/library/papers/9023206 | PubMed |
| 8955283 | Recombinant Treponema pallidum rare outer membrane protein 1 (Tromp1) expressed in Escherichia coli has porin activity and surface antigenic exposure. | J Bacteriol | 1996 | https://conductscience.org/library/papers/8955283 | PubMed |
| 8146139 | Vaccines for bacterial sexually transmitted infections: a realistic goal? | Proc Natl Acad Sci U S A | 1994 | https://conductscience.org/library/papers/8146139 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/778262
GET https://conductscience.org/api/papers/v1/778262/cited_by?page=2